MUNICH--(BUSINESS WIRE)--Major opportunities are on the horizon for personalized medicine and clinical cancer research and treatment, according to Definiens, the global leader in Tissue Phenomics® for oncology diagnostics. The company predicts that the biggest trends driving the industry over the next year will include big data and data quality, immunotherapy, combination treatments and predictive biomarkers. However, as the industry seeks to overcome unique challenges in each of these areas, advancements will rely on adoption of key drivers.
Help employers find you! Check out all the jobs and post your resume.
